The 6th Workshop on Medical Applications of Spectroscopic X-ray Detectors (SpecXray), hosted by CERN, is a prestigious, invite-only event in Switzerland, whereby experts across a range of medical fields get to commune and share their findings with one another through a series of oral presentations.
Kromek are very pleased to have been invited to this event, where our collaborator Dr. Thomas Zillhardt from the University of Manchester will be showcasing our joint progress in our funded Quantum Digital Tomosynthesis (QDT) project. Similarly to Kromek’s Low-Dose MBI Project, the aim of QDT project is to improve the breast cancer diagnosis by providing better and more precise tools to improve the outcome of breast surgeries.
Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets.